Global and United States In Vitro Diagnostic/IVD Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Diagnostic/IVD Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Instruments
1.2.3 Reagents
1.3 Market by Application
1.3.1 Global In Vitro Diagnostic/IVD Market Share by Application: 2020 VS 2026
1.3.2 Diabetes
1.3.3 Oncology
1.3.4 Cardiology
1.3.5 Nephrology
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Diagnostic/IVD Market Perspective (2015-2026)
2.2 Global In Vitro Diagnostic/IVD Growth Trends by Regions
2.2.1 In Vitro Diagnostic/IVD Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 In Vitro Diagnostic/IVD Historic Market Share by Regions (2015-2020)
2.2.3 In Vitro Diagnostic/IVD Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Diagnostic/IVD Players by Market Size
3.1.1 Global Top In Vitro Diagnostic/IVD Players by Revenue (2015-2020)
3.1.2 Global In Vitro Diagnostic/IVD Revenue Market Share by Players (2015-2020)
3.2 Global In Vitro Diagnostic/IVD Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by In Vitro Diagnostic/IVD Revenue
3.4 Global In Vitro Diagnostic/IVD Market Concentration Ratio
3.4.1 Global In Vitro Diagnostic/IVD Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Diagnostic/IVD Revenue in 2019
3.5 Key Players In Vitro Diagnostic/IVD Area Served
3.6 Key Players In Vitro Diagnostic/IVD Product Solution and Service
3.7 Date of Enter into In Vitro Diagnostic/IVD Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Diagnostic/IVD Breakdown Data by Type (2015-2026)
4.1 Global In Vitro Diagnostic/IVD Historic Market Size by Type (2015-2020)
4.2 Global In Vitro Diagnostic/IVD Forecasted Market Size by Type (2021-2026)
5 In Vitro Diagnostic/IVD Breakdown Data by Application (2015-2026)
5.1 Global In Vitro Diagnostic/IVD Historic Market Size by Application (2015-2020)
5.2 Global In Vitro Diagnostic/IVD Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America In Vitro Diagnostic/IVD Market Size (2015-2026)
6.2 North America In Vitro Diagnostic/IVD Market Size by Type (2015-2020)
6.3 North America In Vitro Diagnostic/IVD Market Size by Application (2015-2020)
6.4 North America In Vitro Diagnostic/IVD Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe In Vitro Diagnostic/IVD Market Size (2015-2026)
7.2 Europe In Vitro Diagnostic/IVD Market Size by Type (2015-2020)
7.3 Europe In Vitro Diagnostic/IVD Market Size by Application (2015-2020)
7.4 Europe In Vitro Diagnostic/IVD Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China In Vitro Diagnostic/IVD Market Size (2015-2026)
8.2 China In Vitro Diagnostic/IVD Market Size by Type (2015-2020)
8.3 China In Vitro Diagnostic/IVD Market Size by Application (2015-2020)
8.4 China In Vitro Diagnostic/IVD Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan In Vitro Diagnostic/IVD Market Size (2015-2026)
9.2 Japan In Vitro Diagnostic/IVD Market Size by Type (2015-2020)
9.3 Japan In Vitro Diagnostic/IVD Market Size by Application (2015-2020)
9.4 Japan In Vitro Diagnostic/IVD Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia In Vitro Diagnostic/IVD Market Size (2015-2026)
10.2 Southeast Asia In Vitro Diagnostic/IVD Market Size by Type (2015-2020)
10.3 Southeast Asia In Vitro Diagnostic/IVD Market Size by Application (2015-2020)
10.4 Southeast Asia In Vitro Diagnostic/IVD Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Roche Diagnostics (Switzerland)
11.1.1 Roche Diagnostics (Switzerland) Company Details
11.1.2 Roche Diagnostics (Switzerland) Business Overview
11.1.3 Roche Diagnostics (Switzerland) In Vitro Diagnostic/IVD Introduction
11.1.4 Roche Diagnostics (Switzerland) Revenue in In Vitro Diagnostic/IVD Business (2015-2020))
11.1.5 Roche Diagnostics (Switzerland) Recent Development
11.2 Siemens Healthineers (Germany)
11.2.1 Siemens Healthineers (Germany) Company Details
11.2.2 Siemens Healthineers (Germany) Business Overview
11.2.3 Siemens Healthineers (Germany) In Vitro Diagnostic/IVD Introduction
11.2.4 Siemens Healthineers (Germany) Revenue in In Vitro Diagnostic/IVD Business (2015-2020)
11.2.5 Siemens Healthineers (Germany) Recent Development
11.3 Danaher Corporation (US)
11.3.1 Danaher Corporation (US) Company Details
11.3.2 Danaher Corporation (US) Business Overview
11.3.3 Danaher Corporation (US) In Vitro Diagnostic/IVD Introduction
11.3.4 Danaher Corporation (US) Revenue in In Vitro Diagnostic/IVD Business (2015-2020)
11.3.5 Danaher Corporation (US) Recent Development
11.4 Abbott Laboratories (US)
11.4.1 Abbott Laboratories (US) Company Details
11.4.2 Abbott Laboratories (US) Business Overview
11.4.3 Abbott Laboratories (US) In Vitro Diagnostic/IVD Introduction
11.4.4 Abbott Laboratories (US) Revenue in In Vitro Diagnostic/IVD Business (2015-2020)
11.4.5 Abbott Laboratories (US) Recent Development
11.5 Thermo Fisher Scientific (US)
11.5.1 Thermo Fisher Scientific (US) Company Details
11.5.2 Thermo Fisher Scientific (US) Business Overview
11.5.3 Thermo Fisher Scientific (US) In Vitro Diagnostic/IVD Introduction
11.5.4 Thermo Fisher Scientific (US) Revenue in In Vitro Diagnostic/IVD Business (2015-2020)
11.5.5 Thermo Fisher Scientific (US) Recent Development
11.6 Johnson and Johnson (US)
11.6.1 Johnson and Johnson (US) Company Details
11.6.2 Johnson and Johnson (US) Business Overview
11.6.3 Johnson and Johnson (US) In Vitro Diagnostic/IVD Introduction
11.6.4 Johnson and Johnson (US) Revenue in In Vitro Diagnostic/IVD Business (2015-2020)
11.6.5 Johnson and Johnson (US) Recent Development
11.7 Bio-Rad Laboratories (US)
11.7.1 Bio-Rad Laboratories (US) Company Details
11.7.2 Bio-Rad Laboratories (US) Business Overview
11.7.3 Bio-Rad Laboratories (US) In Vitro Diagnostic/IVD Introduction
11.7.4 Bio-Rad Laboratories (US) Revenue in In Vitro Diagnostic/IVD Business (2015-2020)
11.7.5 Bio-Rad Laboratories (US) Recent Development
11.8 Sysmex Corporation (Japan)
11.8.1 Sysmex Corporation (Japan) Company Details
11.8.2 Sysmex Corporation (Japan) Business Overview
11.8.3 Sysmex Corporation (Japan) In Vitro Diagnostic/IVD Introduction
11.8.4 Sysmex Corporation (Japan) Revenue in In Vitro Diagnostic/IVD Business (2015-2020)
11.8.5 Sysmex Corporation (Japan) Recent Development
11.9 bioMérieux (France)
11.9.1 bioMérieux (France) Company Details
11.9.2 bioMérieux (France) Business Overview
11.9.3 bioMérieux (France) In Vitro Diagnostic/IVD Introduction
11.9.4 bioMérieux (France) Revenue in In Vitro Diagnostic/IVD Business (2015-2020)
11.9.5 bioMérieux (France) Recent Development
11.10 DiaSorin (Italy)
11.10.1 DiaSorin (Italy) Company Details
11.10.2 DiaSorin (Italy) Business Overview
11.10.3 DiaSorin (Italy) In Vitro Diagnostic/IVD Introduction
11.10.4 DiaSorin (Italy) Revenue in In Vitro Diagnostic/IVD Business (2015-2020)
11.10.5 DiaSorin (Italy) Recent Development
11.11 Ortho Clinical Diagnostics (US)
10.11.1 Ortho Clinical Diagnostics (US) Company Details
10.11.2 Ortho Clinical Diagnostics (US) Business Overview
10.11.3 Ortho Clinical Diagnostics (US) In Vitro Diagnostic/IVD Introduction
10.11.4 Ortho Clinical Diagnostics (US) Revenue in In Vitro Diagnostic/IVD Business (2015-2020)
10.11.5 Ortho Clinical Diagnostics (US) Recent Development
11.12 Agilent Technologies (US)
10.12.1 Agilent Technologies (US) Company Details
10.12.2 Agilent Technologies (US) Business Overview
10.12.3 Agilent Technologies (US) In Vitro Diagnostic/IVD Introduction
10.12.4 Agilent Technologies (US) Revenue in In Vitro Diagnostic/IVD Business (2015-2020)
10.12.5 Agilent Technologies (US) Recent Development
11.13 QIAGEN (Germany)
10.13.1 QIAGEN (Germany) Company Details
10.13.2 QIAGEN (Germany) Business Overview
10.13.3 QIAGEN (Germany) In Vitro Diagnostic/IVD Introduction
10.13.4 QIAGEN (Germany) Revenue in In Vitro Diagnostic/IVD Business (2015-2020)
10.13.5 QIAGEN (Germany) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global In Vitro Diagnostic/IVD Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Instruments
Table 4. Key Players of Reagents
Table 5. Global In Vitro Diagnostic/IVD Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global In Vitro Diagnostic/IVD Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global In Vitro Diagnostic/IVD Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global In Vitro Diagnostic/IVD Market Share by Regions (2015-2020)
Table 9. Global In Vitro Diagnostic/IVD Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global In Vitro Diagnostic/IVD Market Share by Regions (2021-2026)
Table 11. In Vitro Diagnostic/IVD Market Market Trends
Table 12. In Vitro Diagnostic/IVD Market Drivers
Table 13. In Vitro Diagnostic/IVD Market Challenges
Table 14. In Vitro Diagnostic/IVD Market Restraints
Table 15. Global In Vitro Diagnostic/IVD Revenue by Players (2015-2020) (US$ Million)
Table 16. Global In Vitro Diagnostic/IVD Market Share by Players (2015-2020)
Table 17. Global Top In Vitro Diagnostic/IVD Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In Vitro Diagnostic/IVD as of 2019)
Table 18. Global In Vitro Diagnostic/IVD by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players In Vitro Diagnostic/IVD Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global In Vitro Diagnostic/IVD Market Size by Type (2015-2020) (US$ Million)
Table 23. Global In Vitro Diagnostic/IVD Market Size Share by Type (2015-2020)
Table 24. Global In Vitro Diagnostic/IVD Revenue Market Share by Type (2021-2026)
Table 25. Global In Vitro Diagnostic/IVD Market Size Share by Application (2015-2020)
Table 26. Global In Vitro Diagnostic/IVD Market Size by Application (2015-2020) (US$ Million)
Table 27. Global In Vitro Diagnostic/IVD Market Size Share by Application (2021-2026)
Table 28. North America In Vitro Diagnostic/IVD Market Size by Type (2015-2020) (US$ Million)
Table 29. North America In Vitro Diagnostic/IVD Market Share by Type (2015-2020)
Table 30. North America In Vitro Diagnostic/IVD Market Size by Application (2015-2020) (US$ Million)
Table 31. North America In Vitro Diagnostic/IVD Market Share by Application (2015-2020)
Table 32. North America In Vitro Diagnostic/IVD Market Size by Country (US$ Million) (2015-2020)
Table 33. North America In Vitro Diagnostic/IVD Market Share by Country (2015-2020)
Table 34. Europe In Vitro Diagnostic/IVD Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe In Vitro Diagnostic/IVD Market Share by Type (2015-2020)
Table 36. Europe In Vitro Diagnostic/IVD Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe In Vitro Diagnostic/IVD Market Share by Application (2015-2020)
Table 38. Europe In Vitro Diagnostic/IVD Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe In Vitro Diagnostic/IVD Market Share by Country (2015-2020)
Table 40. China In Vitro Diagnostic/IVD Market Size by Type (2015-2020) (US$ Million)
Table 41. China In Vitro Diagnostic/IVD Market Share by Type (2015-2020)
Table 42. China In Vitro Diagnostic/IVD Market Size by Application (2015-2020) (US$ Million)
Table 43. China In Vitro Diagnostic/IVD Market Share by Application (2015-2020)
Table 44. China In Vitro Diagnostic/IVD Market Size by Region (US$ Million) (2015-2020)
Table 45. China In Vitro Diagnostic/IVD Market Share by Region (2015-2020)
Table 46. Japan In Vitro Diagnostic/IVD Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan In Vitro Diagnostic/IVD Market Share by Type (2015-2020)
Table 48. Japan In Vitro Diagnostic/IVD Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan In Vitro Diagnostic/IVD Market Share by Application (2015-2020)
Table 50. Japan In Vitro Diagnostic/IVD Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan In Vitro Diagnostic/IVD Market Share by Country (2015-2020)
Table 52. Southeast Asia In Vitro Diagnostic/IVD Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia In Vitro Diagnostic/IVD Market Share by Type (2015-2020)
Table 54. Southeast Asia In Vitro Diagnostic/IVD Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia In Vitro Diagnostic/IVD Market Share by Application (2015-2020)
Table 56. Southeast Asia In Vitro Diagnostic/IVD Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia In Vitro Diagnostic/IVD Market Share by Country (2015-2020)
Table 58. Roche Diagnostics (Switzerland) Company Details
Table 59. Roche Diagnostics (Switzerland) Business Overview
Table 60. Roche Diagnostics (Switzerland) Product
Table 61. Roche Diagnostics (Switzerland) Revenue in In Vitro Diagnostic/IVD Business (2015-2020) (US$ Million)
Table 62. Roche Diagnostics (Switzerland) Recent Development
Table 63. Siemens Healthineers (Germany) Company Details
Table 64. Siemens Healthineers (Germany) Business Overview
Table 65. Siemens Healthineers (Germany) Product
Table 66. Siemens Healthineers (Germany) Revenue in In Vitro Diagnostic/IVD Business (2015-2020) (US$ Million)
Table 67. Siemens Healthineers (Germany) Recent Development
Table 68. Danaher Corporation (US) Company Details
Table 69. Danaher Corporation (US) Business Overview
Table 70. Danaher Corporation (US) Product
Table 71. Danaher Corporation (US) Revenue in In Vitro Diagnostic/IVD Business (2015-2020) (US$ Million)
Table 72. Danaher Corporation (US) Recent Development
Table 73. Abbott Laboratories (US) Company Details
Table 74. Abbott Laboratories (US) Business Overview
Table 75. Abbott Laboratories (US) Product
Table 76. Abbott Laboratories (US) Revenue in In Vitro Diagnostic/IVD Business (2015-2020) (US$ Million)
Table 77. Abbott Laboratories (US) Recent Development
Table 78. Thermo Fisher Scientific (US) Company Details
Table 79. Thermo Fisher Scientific (US) Business Overview
Table 80. Thermo Fisher Scientific (US) Product
Table 81. Thermo Fisher Scientific (US) Revenue in In Vitro Diagnostic/IVD Business (2015-2020) (US$ Million)
Table 82. Thermo Fisher Scientific (US) Recent Development
Table 83. Johnson and Johnson (US) Company Details
Table 84. Johnson and Johnson (US) Business Overview
Table 85. Johnson and Johnson (US) Product
Table 86. Johnson and Johnson (US) Revenue in In Vitro Diagnostic/IVD Business (2015-2020) (US$ Million)
Table 87. Johnson and Johnson (US) Recent Development
Table 88. Bio-Rad Laboratories (US) Company Details
Table 89. Bio-Rad Laboratories (US) Business Overview
Table 90. Bio-Rad Laboratories (US) Product
Table 91. Bio-Rad Laboratories (US) Revenue in In Vitro Diagnostic/IVD Business (2015-2020) (US$ Million)
Table 92. Bio-Rad Laboratories (US) Recent Development
Table 93. Sysmex Corporation (Japan) Business Overview
Table 94. Sysmex Corporation (Japan) Product
Table 95. Sysmex Corporation (Japan) Company Details
Table 96. Sysmex Corporation (Japan) Revenue in In Vitro Diagnostic/IVD Business (2015-2020) (US$ Million)
Table 97. Sysmex Corporation (Japan) Recent Development
Table 98. bioMérieux (France) Company Details
Table 99. bioMérieux (France) Business Overview
Table 100. bioMérieux (France) Product
Table 101. bioMérieux (France) Revenue in In Vitro Diagnostic/IVD Business (2015-2020) (US$ Million)
Table 102. bioMérieux (France) Recent Development
Table 103. DiaSorin (Italy) Company Details
Table 104. DiaSorin (Italy) Business Overview
Table 105. DiaSorin (Italy) Product
Table 106. DiaSorin (Italy) Revenue in In Vitro Diagnostic/IVD Business (2015-2020) (US$ Million)
Table 107. DiaSorin (Italy) Recent Development
Table 108. Ortho Clinical Diagnostics (US) Company Details
Table 109. Ortho Clinical Diagnostics (US) Business Overview
Table 110. Ortho Clinical Diagnostics (US) Product
Table 111. Ortho Clinical Diagnostics (US) Revenue in In Vitro Diagnostic/IVD Business (2015-2020) (US$ Million)
Table 112. Ortho Clinical Diagnostics (US) Recent Development
Table 113. Agilent Technologies (US) Company Details
Table 114. Agilent Technologies (US) Business Overview
Table 115. Agilent Technologies (US) Product
Table 116. Agilent Technologies (US) Revenue in In Vitro Diagnostic/IVD Business (2015-2020) (US$ Million)
Table 117. Agilent Technologies (US) Recent Development
Table 118. QIAGEN (Germany) Company Details
Table 119. QIAGEN (Germany) Business Overview
Table 120. QIAGEN (Germany) Product
Table 121. QIAGEN (Germany) Revenue in In Vitro Diagnostic/IVD Business (2015-2020) (US$ Million)
Table 122. QIAGEN (Germany) Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of FiguresFigure 1. Global In Vitro Diagnostic/IVD Market Share by Type: 2020 VS 2026
Figure 2. Instruments Features
Figure 3. Reagents Features
Figure 4. Global In Vitro Diagnostic/IVD Market Share by Application: 2020 VS 2026
Figure 5. Diabetes Case Studies
Figure 6. Oncology Case Studies
Figure 7. Cardiology Case Studies
Figure 8. Nephrology Case Studies
Figure 9. In Vitro Diagnostic/IVD Report Years Considered
Figure 10. Global In Vitro Diagnostic/IVD Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global In Vitro Diagnostic/IVD Market Share by Regions: 2020 VS 2026
Figure 12. Global In Vitro Diagnostic/IVD Market Share by Regions (2021-2026)
Figure 13. Global In Vitro Diagnostic/IVD Market Share by Players in 2019
Figure 14. Global Top In Vitro Diagnostic/IVD Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In Vitro Diagnostic/IVD as of 2019
Figure 15. The Top 10 and 5 Players Market Share by In Vitro Diagnostic/IVD Revenue in 2019
Figure 16. North America In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Rest of Europe In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa In Vitro Diagnostic/IVD Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Roche Diagnostics (Switzerland) Revenue Growth Rate in In Vitro Diagnostic/IVD Business (2015-2020)
Figure 44. Siemens Healthineers (Germany) Revenue Growth Rate in In Vitro Diagnostic/IVD Business (2015-2020)
Figure 45. Danaher Corporation (US) Revenue Growth Rate in In Vitro Diagnostic/IVD Business (2015-2020)
Figure 46. Abbott Laboratories (US) Revenue Growth Rate in In Vitro Diagnostic/IVD Business (2015-2020)
Figure 47. Thermo Fisher Scientific (US) Revenue Growth Rate in In Vitro Diagnostic/IVD Business (2015-2020)
Figure 48. Johnson and Johnson (US) Revenue Growth Rate in In Vitro Diagnostic/IVD Business (2015-2020)
Figure 49. Bio-Rad Laboratories (US) Revenue Growth Rate in In Vitro Diagnostic/IVD Business (2015-2020)
Figure 50. Sysmex Corporation (Japan) Revenue Growth Rate in In Vitro Diagnostic/IVD Business (2015-2020)
Figure 51. bioMérieux (France) Revenue Growth Rate in In Vitro Diagnostic/IVD Business (2015-2020)
Figure 52. DiaSorin (Italy) Revenue Growth Rate in In Vitro Diagnostic/IVD Business (2015-2020)
Figure 53. Ortho Clinical Diagnostics (US) Revenue Growth Rate in In Vitro Diagnostic/IVD Business (2015-2020)
Figure 54. Agilent Technologies (US) Revenue Growth Rate in In Vitro Diagnostic/IVD Business (2015-2020)
Figure 55. QIAGEN (Germany) Revenue Growth Rate in In Vitro Diagnostic/IVD Business (2015-2020)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed